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J. Enouf, R. Bredoux and S. Levy-Toledano. Unite INSERM 150, HSpital Lariboisiere,
Paris.
It is generally believed that calcium ions play a key role in regulation of platelet
functions. One of the main storage pool of calcium in the platelet is the dense tubular
system. A platelet membrane fraction which actively sequesters calcium has been isolated
and characterized. Phenothiazine analogues have been tested on the characterized calcium
uptake into platelet membrane vesicles. The drugs are competitive inhibitors of calcium
transport and a relationship between structure-activity has been established. Evidence
for two analogues with an apparent Ki of the same order of magnitude than chlorpromazine
and trifluoperazine was found. Furthermore a strong correlation was found between the
inhibition of the calcium uptake and the inhibition of the ionophore-induced platelet
activation which confirms the role of intracellular calcium movements in the regulation
of the ionophore-induced platelet activation. The possible action mechanism of these
phenothiazine analogues namely on the involvement of calmodulin within the platelet
system is discussed.
ANTIAGGREGANT TREATMENT VERSUS ORAL ANTICOAGULATION IN PREVENTING
020 THROMBOSIS OF AORTO-CORONARY BYPASS GRAFTS.
M. Rothlin, N. Pfluger, K. Speiser, N. Goebel. University Hospital Zflrich, Switzerland.
Aorto-coronary bypass graft occlusion during the early weeks after surgery is caused
mainly by thrombosis and oral anticoagulant therapy has been shown to improve graft
patency. To compare the effect of Ticlopidine (T) an antiaggregant drug to that of oral
anticoagulation by Acenocoumarol (A) in a prospective randomized trial 76 patients (p)
received T 2x250 mg daily and 72 p received A according to prothrombine time for the
first 3 postoperative months. Graft patency was then tested by angiography. The two p
groups were comparable in respect to age, symptoms, ejection fraction, coronary anatomy
and number of bypass grafts implanted.
The occlusion rate was 16 % in p with T and 20 % in p with A (n.s.). In small arte-
ries (1-1,5mm) the occlusion rate was 20 % with T and 24 % with A, in larger arteries
(2mm or more) occlusion rates were 12 % with T and 16 % with A.
In conclusion the effect of Ticlopidine is at least equal to that of oral anticoa-
gulation of out-patients for the prevention of graft thrombosis during the first 3
postoperative months.
